After normalization, the levels of marker gene expression were determined by expressing the ratio of BPC-157-modulated genes to control genes
5g), including a reduction of osteoclast-covered bone area (Fig
The Journal of biological chemistry, 289(28), 1950819518
However, the largest Phase IIb trial involving 536 subjects failed to demonstrate statistically significant weight loss compared to placebo at the primary 12-week endpoint, leading Metabolic Pharmaceuticals to terminate development in 2007
Who B12 Injections is For Good Candidates
Some reviews describe a broad range of experimental findings, but there remains a gap between promising research and established, FDA-approved clinical use